Protagonist Therapeutics (PTGX) Earnings
|
Expand Research on PTGX
| Next EPS Date | 5/1/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +10.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +25.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/20 |  |
Q120 | -$0.72 | -$0.69 | -$0.03 | N/A | $1.48M | N/A |  | | Details |
| 11/8/22 | Q322 | -$0.70 | -$0.91 | +$0.21 | $10.29M | $225K | N/A | | | Details | |
| 8/4/22 | Q222 | -$0.69 | -$0.94 | +$0.25 | $2.27M | $6.22M | N/A | | | Details | |
8/3/23  |
Q223 | -$0.68 | -$0.65 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 3/10/20 | |
Q419 | -$0.63 | -$0.65 | +$0.02 | $2.72M | $3.22M | N/A | | | Details |
| 3/12/19 | |
Q418 | -$0.57 | -$0.47 | -$0.10 | $2.35M | $4.83M | N/A | | | Details |
| 3/7/18 | |
Q417 | -$0.15 | N/A | N/A | N/A | N/A | = | | | Details |
| 5/1/24 | Q124 | N/A | $1.19 | N/A | N/A | $120M | N/A | N/A | N/A |
